Patient Care · Regulora for IBS

A Health Canada authorized digital therapeutic for IBS.

Regulora^® is a prescription-free, drug-free digital therapeutic that delivers gut-directed hypnotherapy through a mobile app. Built on the North Carolina Protocol, and distributed by Launchit Solutions under Health Canada authorization.

What Regulora Is

A 12-week, app-delivered course of gut-directed hypnotherapy for people living with IBS.

IBS is one of the most prevalent functional GI conditions in Canada. The drug toolkit is limited, side effects are common, and gut-directed hypnotherapy has stronger guideline support than most patients ever hear about. The barrier has always been access.

Regulora^® removes the access barrier. A clinically validated protocol, delivered in an app, at a fraction of the cost of in-person hypnotherapy, with no waitlist and no appointment scheduling.

See how Regulora works on regulora.ca →

7 self-administered sessions, 30 minutes each, one every other week
12 weeks to lasting results, because the brain-gut axis is what is being retrained
Drug-free, no prescription required, works alongside any current IBS treatment
One-time payment, no subscriptions
Available on iOS and Android

Real Results

Patient-reported outcomes from the North Carolina Protocol delivered through Regulora®.

87%

of participants would recommend Regulora^® to others

68%

reported overall satisfaction with the treatment

12 weeks

to lasting symptom relief, without ongoing app use

Gut-directed hypnotherapy is not alternative medicine. It is in the Canadian Association of Gastroenterology Clinical Practice Guidelines for IBS, and Regulora^® is the Health Canada authorized way to deliver it digitally

Read the clinical summary on the North Carolina Protocol (PDF) →

Backed by Science and Regulators

Authorized, guideline-supported, and clinically validated.

Regulora^® is not a wellness app with a clinical claim. It is a regulated digital therapeutic with peer-reviewed evidence behind it.

Health Canada Authorized

Launchit Solutions Inc. is authorized by Health Canada to sell Regulora^® in Canada as a digital therapeutic for IBS.

Clinical Practice Guidelines

Gut-directed hypnotherapy is included in the Canadian Association of Gastroenterology’s Clinical Practice Guidelines for the Management of IBS.

North Carolina Protocol

Developed by experts in gut-brain axis research with years of published clinical evidence behind it.

For Clinicians and Partners

A non-pharmacological IBS option that fits into existing care plans.

Regulora^® is a take-home option that supports patients between visits without adding a prescription, a side effect profile, or a referral wait. It works alongside existing IBS treatment, not in place of it.

Visit the HCP portal at hcp.regulora.ca →

For clinicians. No prescription required. A non-drug option for patients who have exhausted or do not tolerate pharmacotherapy.
For manufacturers. Co-promotion alongside a complementary IBS therapy or inclusion in a PSP as a non-drug adherence aid.
For employers and insurers. One-time covered benefit for members managing IBS, with measurable patient-reported outcomes.
For distributors. International market entry where digital therapeutic regulation supports it. Configuration, not new builds.

Ready to talk Regulora®?

Patients can buy Regulora^® directly. Clinicians, manufacturers, employers, and distributors can scope a partnership in a single call.